Mobia Medical Inc Revenue Growth Rates (MOBI), Current and Historic Growth - CSIMarket
CSIMarket
 


Mobia Medical Inc   (Nasdaq: MOBI)
 

MOBI's Revenue Growth by Quarter and Year

Mobia Medical Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MOBI/growth
https://api.csimarket.com/api/v1/companies/MOBI/fundamentals
https://api.csimarket.com/api/v1/companies/MOBI/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
MOBI Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 15.62
2nd Quarter June 13.51
1st Quarter March 12.07
FY 41.20





MOBI Revenue third quarter 2026 Y/Y Growth Comment
Mobia Medical Inc achieved in the third quarter 2026, above Company average Revenue surge of 134.12% year on year, to $ 15.62 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue growth. While Mobia Medical Inc ' s Revenue doubling of 134.12% ranks overall at the positon no. 734 in the third quarter 2026.




MOBI Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 134.12 %
2nd Quarter June 138.69 %
1st Quarter March -
FY   -

Financial Statements
Mobia Medical Inc 's third quarter 2026 Revenue $ 15.62 millions MOBI's Income Statement
Mobia Medical Inc 's third quarter 2025 Revenue $ 6.67 millions Quarterly MOBI's Income Statement


MOBI Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 15.59 %
2nd Quarter June 11.93 %
1st Quarter March 33.96 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #120
Overall #734

Revenue Y/Y Growth Statistics
High Average Low
17.89 % 14.87 % 11.85 %
(Jun 30 2025)   (Jun 30 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #120
Overall #734
Revenue Y/Y Growth Statistics
High Average Low
17.89 % 14.87 % 11.85 %
(Jun 30 2025)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Mobia Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
17.89 % 14.87 % 11.85 %
(Jun 30 2025)  


MOBI's III. Quarter Q/Q Revenue Comment
Mobia Medical Inc achieved in the III. Quarter 2026 above company average sequential Revenue jump of 15.59%, to $ 15.62 millions, from $13.51 millions in the second quarter.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Mobia Medical Inc 's Revenue growth quarter on quarter, overall rank is 734.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #120
Overall #734
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #120
Overall #734
Revenue Q/Q Growth Statistics
High Average Low
17.89 % 14.87 % 11.85 %
(Jun 30 2025)  


MOBI's III. Quarter Q/Q Revenue Comment
Mobia Medical Inc achieved in the III. Quarter 2026 above company average sequential Revenue jump of 15.59%, to $ 15.62 millions, from $13.51 millions in the second quarter.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Mobia Medical Inc 's Revenue growth quarter on quarter, overall rank is 734.


Mobia Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending 12 Months Ending 12 Months Ending 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment
In the Mar 31 2026 period, Mobia Medical Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Mobia Medical Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2026 period, Mobia Medical Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Mobia Medical Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MOBI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Urogen Pharma Ltd 227.16%$ 227.161 millions
Dianthus Therapeutics Inc 205.56%$ 205.556 millions
Bridgebio Pharma Inc 192.60%$ 192.602 millions
Bicycle Therapeutics Plc190.24%$ 190.242 millions
Eton Pharmaceuticals Inc 165.04%$ 165.042 millions
Sera Prognostics Inc 162.50%$ 162.500 millions
Camp4 Therapeutics Corporation138.87%$ 138.868 millions
Sonida Senior Living Inc 114.40%$ 114.402 millions
Verastem Inc 113.59%$ 113.592 millions
Keros Therapeutics Inc 88.77%$ 88.766 millions
Profound Medical Corp 85.86%$ 85.857 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions


About Mobia Medical Inc Revenue Growth Rates (MOBI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Mobia Medical Inc (CIK 1489993).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-450041
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Mobia Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.